Heartland Advisors Inc. acquired a new position in shares of Humana Inc. (NYSE:HUM – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 29,632 shares of the insurance provider’s stock, valued at approximately $11,770,000.
Other large investors have also bought and sold shares of the company. Montag A & Associates Inc. grew its position in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Humana in the second quarter worth about $26,000. Fideuram Asset Management Ireland dac bought a new position in shares of Humana in the fourth quarter worth about $27,000. Trust Co. of Vermont acquired a new stake in shares of Humana in the 2nd quarter valued at approximately $28,000. Finally, Reflection Asset Management bought a new stake in shares of Humana during the 4th quarter valued at approximately $29,000. 92.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on HUM shares. Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective for the company in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft started coverage on shares of Humana in a research report on Thursday, July 30th. They issued a “hold” rating on the stock. William Blair initiated coverage on Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating for the company. Wolfe Research raised Humana from a “peer perform” rating to an “outperform” rating in a report on Thursday, July 30th. Finally, Cantor Fitzgerald boosted their price objective on Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 7th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $395.22.
Humana Trading Down 0.4%
HUM opened at $379.22 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The company’s 50 day moving average price is $383.38 and its two-hundred day moving average price is $281.59. The firm has a market capitalization of $45.54 billion, a price-to-earnings ratio of 35.88, a PEG ratio of 2.18 and a beta of 0.72.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter last year, the firm earned $6.27 earnings per share. As a group, research analysts predict that Humana Inc. will post 9.08 earnings per share for the current year.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
